The International Treatment Preparedness Coalition (ITPC) supports the patent pre-grant opposition that was filed on 13 April 2015 by the Fundación Grupo Efecto Positivo (FGEP) and the Argentinian Network of Positive People (Redar Positive). The patent was filed at Argentina’s patent office and challenges the validity of a patent application submitted by Gilead Sciences on […]
On Human Rights Day, the International Treatment Preparedness Coalition (ITPC) is proud to announce that our Advocacy for Community Treatment (ACT) Toolkit is now available in English, French, Spanish and Russian. The ACT Toolkit facilitates community activists to become effective advocates for HIV treatment access. It includes a special focus on supporting key populations and ensuring everyone’s right to health is respected.
Sign ITPC’s petition to Gilead A recent decision by India’s Patent Office rejecting one of Gilead’s key patents for sofosbuvir is an important step for treatment activists. But Gilead is using every trick in the book to get the decision reversed, including lobbying the Indian Government. Sign our petition today to expand Hep C treatment!
News summary On November 24-28, 2014, the International Treatment Preparedness Coalition (ITPC) and the AIDS and Rights Alliance for Southern Africa (ARASA) held a joint workshop training, titled Community Involvement in Access to Affordable HIV Treatment: Focus on the Influence of Intellectual Property & Free Trade Agreements, at the Aviator Hotel in Johannesburg, South Africa. […]
In 2013, the International Treatment Preparedness Coalition (ITPC), through Bridging the Gaps, supported KeNPUD with a small grant to grow their organization. Mid-way through their ITPC grant, KeNPUD has conducted 15 advocacy actions, conseled 85 people, and held HIV education workshops for over 200 people. They continue to do health outreach to mobilize people to […]
News summary The report, “ Global Action with Local Impact: Why Advocacy Matters ,” details strategies used and outcomes achieved by ITPC and our other global network partners focused on key populations under the Bridging the Gaps programme. The report examines the role of international advocacy in addressing HIV among key populations, including people living […]
In July 2014, 23 community leaders came together at the Bellagio Centre, Italy for a three day meeting to assess the state of the HIV/AIDS movement. The meeting resulted in this Call to Action. The Bellagio meeting brought together a diverse group of academics, health practitioners, activists and policy makers, including HIV and human rights […]
We knew it wasn’t going to be easy to protest at the recent Gilead Press Conference in New Delhi, held on 15th September 2014. The press conference was in a posh, five-star hotel. So we thought we’d do a silent protest, to get our message across to Gilead, Indian pharmaceutical companies and the local press […]
Forty activists and treatment advocates from around the world are in Bangkok from 22 to 25 February 2014 to attend the first World Community Advisory Board (CAB) meeting on Hepatitis C Virus (HCV) treatment. The participants will also meet with key pharmaceutical companies producing medicines to treat HCV. Members of ITPC’s Middle East & North […]
On 6 and 7 June in Minsk, Belarus, the Public Health and Social Development Foundation, FOCUS-MEDIA, with organizational and logistical support from ITPCru, held an international conference for women affected by HIV across the Eastern Europe and Central Asia region. Participants included activists from the EVA Women’s Network, the Candle Foundation (Russia), the Community of […]
Today, the Middle East North Africa (MENA) region is considered to have one of fastest growing HIV epidemics in the world and the lowest rate of treatment coverage – with only 14% of people in need receiving antiretroviral therapy. ITPC MENA and ALCS-Maroc recently organized a World Community Advisory Board meeting, bringing together 17 activists […]
Between June and August 2014, the Patients in Control initiative, a grassroots movement centered on treatment advocacy in Russia, received nearly 25 private appeals from patients regarding the unexpected replacement of their treatment regimens. These appeals came from ten regions across the nation, including Ivanovo, Tatarstan, Kaliningrad, Krasnoyarsk, Murmansk, Moscow, Nizhny Novgorod, Perm, Rostov-on-Don and […]